Recent developments in oral chemotherapy options for gastric carcinoma.
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 58 (3) , 85-90
- https://doi.org/10.2165/00003495-199958003-00012
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.1997
- The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer.1992
- Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.Journal of Clinical Oncology, 1991
- [Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].1990
- Low-dose oral etoposide: a new role for an old drug?Journal of Clinical Oncology, 1990
- Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.Journal of Clinical Oncology, 1990
- Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinomaThe American Journal of Surgery, 1990
- Single-agent oral etoposide for elderly small cell lung cancer patients.1990
- Postoperative adjuvant chemotherapy for gastric cancer, the second report. Analysis of data on 2873 patients followed for five yearsSurgery Today, 1986
- Postoperative adjuvant chemotherapy for gastric carcinoma analysis of data on 1805 patients followed for 5 yearsCancer, 1984